Enforcement record
Warning disclosure naming 警視庁
This page records one action from a Japanese government disclosure, including the published name, governing law, authority, action details, and official source.
Action type
Warning
Law
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
Authority
Ministry of Health, Labour and Welfare
Action date
10 July 2014
Current page: Enforcement record
This screen focuses on one disclosed action: the published name, governing law, authority, facts, source status, and review evidence.
Source verification
Public-source and preservation status
- Publishing authority
- Ministry of Health, Labour and Welfare
- Official source URL
- Recorded by RegBase
- Entity match
- Not confirmed; shown under the published name
- Kiroku preservation
- Queued for preservation
- Captured: Jul 12, 2026, 03:50 PM JST
“Confirmed” means that RegBase matched this record to the cited public disclosure or entity under the stated checks. It does not verify the truth of the disclosure or guarantee the entity’s current status, creditworthiness, or any legal conclusion.
Available sources and saved files are listed in the public documents section below.
Action summary
- Company
- 警視庁Japanese onlyOriginal: 警視庁
- Governing law
- Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices薬機法
- Action type
- Warning警告
- Action date
- 10 July 2014
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
- Industry context
- 薬物販売
Violation
A nationwide inspection was conducted on stores selling so-called 'legal highs' in Tokyo, and warning letters requesting sales suspension were handed to 44 stores.
Show original Japanese text
東京都内のいわゆる「脱法ドラッグ」の販売店舗に対して、一斉立入検査を実施し、44店舗に対して販売自粛の警告書を手交した。
Public documents and saved materials
View official publications and the available saved materials. Purchase a one-time evidence pack to download the compiled files.
Loading materials…
Compliance context
Low-mediumThe authority publicly disclosed a warning based on the cited facts.
Health product law covering pharmaceuticals, medical devices, cosmetics, quasi-drugs, labeling, and advertising.
Use as a lead for review, especially if similar warnings repeat or relate to consumer-facing activity.
This context is an operational aid for review workflows, not a credit opinion or legal conclusion.
Language
日本語版を見る (Japanese)About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.